YAMAUCHI LAB
​
Announcement of Collaboration with TAGCyx biotechnologies Inc.
Prof. Yohei Yamauchi of ETH Zurich and TAGCyx Announces a Research Collaboration for the discovery of a novel Xenoligo® aptamer in the field of infectious diseases field.
March 13th, 2024
Prof. Yohei Yamauchi at ETH Zurich
TAGCyx biotechnologies Inc.
​
Prof. Yohei Yamauchi, Professor of Molecular Medicine at the Institute of Pharmaceutical Sciences (IPW) at ETH Zurich, Zurich, and TAGCyx biotechnologies Inc., Tokyo, announced entering into a research collaboration for the discovery of novel Xenoligo® aptamers in the field of infectious diseases field.Prof. Yohei Yamauchi, MD PhD, is an expert in the area of virus-host interaction of zoonotic viruses such as influenza A virus and SARS-CoV-2. He is interested in the mechanism of how viruses take advantage of host cell processes and pathways to promote cell entry and establish infection to ultimately cause disease. Prof. Yamauchi aims to use this knowledge to inform new concepts for antivirals. TAGCyx has invented its proprietary artificial nucleic acid base-pair technology, Xenoligo® that enables to produce high avidity and selective functional DNA aptamers and is engaged in its own drug discovery business and drug discovery partnerships.Both parties intend to collaborative research to discover and generate novel DNA aptamers for specific targets in the field of infectious diseases using TAGCyx‘s artificial base containing DNA aptamer discovery platform, Xenoligo®, and to evaluate the efficacy of the Xenoligo® aptamers in interfering with infectivity of viruses in Prof. Yamauchi team.For further information, please contact:Prof. Yohei Yamauchi E-Mail: yohei.yamauchi@pharma.ethz.ch
TAGCyx biotechnologies Inc. https://tagcyx.com/en/
E-Mail: info@tagcyx.com
Publication in
Nature Microbiology!
Click image to read paper ↓
Influenza virus uses transportin 1 for vRNP debundling during cell entry
Miyake et al. 2019
.jpg)
Influenza Virus: Methods & Protocols is Out!
Influenza Virus: Methods & Protocols from the well-known Methods in Molecular Biology series (Springer Nature) was edited by Yohei and published on August 28th, 2018. 30 Chapters of protocols and reviews for both the experienced and newcomers to the flu field. The book can be downloaded as an eBook or purchased from amazon.
NEW BLUE LAB
In April 2017, the Yamauchi lab celebrated refurbishment of a new TC lab.
YAMAUCHI LAB MOVES TO BRISTOL
October 1, 2016
Yohei is appointed Reader at University of Bristol, School of Cellular & Molecular Medicine, Faculty of Biomedical Sciences, UK. He leaves Zurich after 8 years at ETH Zurich and University of Zurich, to start a new life back in the UK.
ISIRV OPTIONS IX
August 25, 2016
Yohei gives an invited symposium talk at the OPTIONS IX for THE CONTROL OF INFLUENZA, the world's largest meeting dedicated to Influenza virus research.
YOHEI RECEIVES SWISS PFIZER AWARD
January 28 PM, 2016
Yohei (centre) receives the Swiss Pfizer Research Prize for Infectology, Rheumatology, and Immunology, together with Indranil Banerjee (back row, right) and Yasuyuki Miyake (absent). The award ceremony took place at the Aura in Zurich.
VIRUSES - AT THE FOREFRONT OF VIRUS-HOST INTERACTIONS
January 28 AM, 2016
Yohei gives an invited talk at Viruses 2016 - At the Forefront of Virus-Host Interactions - in Basel, Switzerland.